Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.
Rosenkranz
Stephan
S
Diet
Frank
F
Karasch
Thomas
T
Weihrauch
Julia
J
Wassermann
Klaus
K
Erdmann
Erland
E
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000368:Aged; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010879:Piperazines / Q000627:therapeutic use*; D011658:Pulmonary Fibrosis / Q000150:complications*; D011687:Purines; D011928:Raynaud Disease / Q000150:complications* / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000150:complications*; D000068677:Sildenafil Citrate; D013450:Sulfones
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D020097:Natriuretic Peptide, Brain; D000068677:Sildenafil Citrate; D015106:3',5'-Cyclic-GMP Phosphodiesterases